Johnson & Johnson CFO Joseph Wolk on Q3 results: Very well-positioned into 2024 and beyond

Поделиться
HTML-код
  • Опубликовано: 1 фев 2025

Комментарии • 5

  • @RannyAssaf
    @RannyAssaf Год назад

    Whatever you mean by “Multiple Myoma”, dear “journalists”, nothing like that even exists.

  • @Continentalmunkey88
    @Continentalmunkey88 Год назад

    DJIA shared 95% US-skew, Madhya Dow is 0.1%

  • @ajaysivaramakrishnan7283
    @ajaysivaramakrishnan7283 Год назад

    1/4 a nd 1/8

  • @milton4867
    @milton4867 Год назад

    6% sales increase when you have 20% average price increase on your product is not a good year, it's actually a sign of decline.